Schwertz R, Esser E, Seger R A, Rubinstein A, Hauptmann G, Wahn V
Institut für Immunologie, Universität Heidelberg, Federal Republic of Germany.
Eur J Pediatr. 1991 Jul;150(9):647-51. doi: 10.1007/BF02072626.
Selective homozygous deficiency of the second component of complement, C2, with increased susceptibility to infection was detected in five children of two unrelated families. Because the haemolytic activity of the alternative complement pathway (AP) was in the low normal range, we evaluated the AP activation pattern. Serum levels of factor B measured immunochemically and the haemolytic function of factor B were low normal. Levels of C3d were not increased. Activation products of factor B were undetectable indicating the absence of in vivo activation of AP. Activation of C3 in vitro by activators of the AP (zymosan A and lipopolysaccharide) was profoundly deficient in homozygous C2 deficiency while heterozygous carriers exhibited intermediate values. There was no correlation between serum levels of factor B and in vitro C3 activation. We conclude that defective AP activation may contribute to increased susceptibility to bacterial infections in some patients with homozygous C2 deficiency.
在两个无亲缘关系的家庭的五名儿童中检测到补体第二成分C2的选择性纯合缺陷,并伴有感染易感性增加。由于替代补体途径(AP)的溶血活性处于低正常范围,我们评估了AP的激活模式。免疫化学法测定的B因子血清水平及B因子的溶血功能均为低正常。C3d水平未升高。未检测到B因子的激活产物,表明不存在AP的体内激活。在纯合C2缺陷患者中,AP激活剂(酵母聚糖A和脂多糖)体外激活C3的能力严重不足,而异合子携带者表现为中间值。B因子血清水平与体外C3激活之间无相关性。我们得出结论,AP激活缺陷可能导致一些纯合C2缺陷患者对细菌感染的易感性增加。